Patents by Inventor Lauren Shearman

Lauren Shearman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050107411
    Abstract: A neuropeptide Y Y5 antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep. The present invention further provides for the use of a medicament for carrying out these methods.
    Type: Application
    Filed: December 13, 2002
    Publication date: May 19, 2005
    Inventors: Douglas MacNeil, Lauren Shearman, Leonardus Van Der Ploeg
  • Publication number: 20030059848
    Abstract: The invention is based, in part, on the discovery that the CRY proteins and the PER2 protein function as important modulators of mammalian circadian rhythm. The invention includes methods of modulating the circadian rhythm and identifying compounds that modulate the circadian rhythm.
    Type: Application
    Filed: September 17, 2002
    Publication date: March 27, 2003
    Applicant: The General Hospital Corporation, a Massachusetts corporation
    Inventors: Steven M. Reppert, David R. Weaver, Mark Zylka, Xiaowei Jin, Kazuhiko Kume, Sriram Sathyanarayanan, Lauren Shearman
  • Patent number: 6475744
    Abstract: The invention is based, in part, on the discovery that the CRY proteins and the PER2 protein function as important modulators of mammalian circadian rhythm. The invention includes methods of modulating the circadian rhythm and identifying compounds that modulate the circadian rhythm.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: November 5, 2002
    Assignee: The General Hospital Corporation
    Inventors: Steven M. Reppert, David R. Weaver, Mark Zylka, Xiaowei Jin, Kazuhiko Kume, Sriram Sathyanarayanan, Lauren Shearman